Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results.

Saved in:
Bibliographic Details
Title: Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results.
Authors: McCluskey SM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Muyindike WR; Mbarara University of Science and Technology, Mbarara, Uganda., Nanfuka V; Mbarara University of Science and Technology, Mbarara, Uganda., Omoding D; Mbarara University of Science and Technology, Mbarara, Uganda., Komukama N; Mbarara University of Science and Technology, Mbarara, Uganda., Barigye IT; Mbarara University of Science and Technology, Mbarara, Uganda., Kansiime L; Mbarara University of Science and Technology, Mbarara, Uganda., Tumusiime J; Mbarara University of Science and Technology, Mbarara, Uganda., Aung TN; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Stuckwisch A; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Hedt-Gauthier B; Harvard Medical School, Boston, Massachusetts, USA.; Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Marconi VC; Emory University School of Medicine and Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Moosa MS; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa., Pillay D; Division of Infection and Immunity, University College London, London, United Kingdom., Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Lessells R; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.; Africa Health Research Institute, Durban, South Africa., Siedner MJ; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Africa Health Research Institute, Durban, South Africa.
Source: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e622-e630.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6613
DOI:10.1093/infdis/jiae260